Cargando…
Roux-en-Y Gastric Bypass Improved Insulin Resistance via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia
BACKGROUND: Obesity is a main contributing factor for the development of glucose intolerance and type 2 diabetes mellitus (T2D). Roux-en-Y gastric bypass (RYGB) is believed to be one of the most effective treatments to reduce body weight and improve glucose metabolism. In this study, we sought to ex...
Autores principales: | Shi, Qiping, Wang, Qian, Zhong, Hui, Li, Dehai, Yu, Shuxing, Yang, Hengwen, Wang, Cunchuan, Yin, Zhinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294027/ https://www.ncbi.nlm.nih.gov/pubmed/34337024 http://dx.doi.org/10.1155/2021/5554991 |
Ejemplares similares
-
Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Alter the Gut-Brain Communication
por: Ballsmider, L. A., et al.
Publicado: (2015) -
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
por: Barkholt, Pernille, et al.
Publicado: (2016) -
Hyperoxia Provokes Time- and Dose-Dependent Gut Injury and Endotoxemia and Alters Gut Microbiome and Transcriptome in Mice
por: Li, Yunhang, et al.
Publicado: (2021) -
Laparoscopic Roux-en-“W” Gastric Bypass
por: Rovito, Peter E.
Publicado: (2004) -
How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy?: Roux-en-Y Gastric Bypass efficacy
por: Guimarães, Marta, et al.
Publicado: (2021)